Abstract: Provided is a metastasis-inhibiting composition containing a methylsulfonamide-based derivative compound as an active ingredient. More specifically, the compounds inhibit the activity of chromosome segregation 1-like (CSE1L), and suppress intracellular nuclear transport to inhibit the movement and/or invasion of cancer cells, and thus effectively inhibit metastasis.

Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating an inflammatory disease, comprising a benzofuran-based N-acylhydrazone compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The benzofuran-based N-acylhydrazone compound according to the present disclosure inhibits the activity of NF-?B, which is a major signal transmitter in the inflammatory response, thereby disrupting the initial pathway and process of the biological inflammatory response system and inhibiting inflammatory immune cells and inflammatory cytokines, and thus can prevent and treat various pathological diseases caused by the inflammatory response.

Abstract: The present disclosure relates to a binder, an electrode including the same binder, a secondary battery including the same electrode, a capacitor including the same electrode, and a method of preparing a binder.

Abstract: A gate driver includes a first shift register connected to gate lines, and configured to supply a gate signal to the gate lines in response to a first start pulse, and a second shift register connected to the gate lines and sensing control lines, and configured to supply the gate signal and a sensing signal to the gate lines and the sensing control lines in response to a second start pulse, in which the second shift register is configured to supply the second start pulse at different times in sequential frames.

Abstract: A gate driver includes a first shift register connected to gate lines, and configured to supply a gate signal to the gate lines in response to a first start pulse, and a second shift register connected to the gate lines and sensing control lines, and configured to supply the gate signal and a sensing signal to the gate lines and the sensing control lines in response to a second start pulse, in which the second shift register is configured to supply the second start pulse at different times in sequential frames.

Abstract: A display device includes a display panel including a plurality of pixels connected to data lines and sensing lines, a data driver including a plurality of buffer amplifiers which supplies a first sensing voltage to the data lines during a first sensing period and a sensor which receives a first sensing signal from the pixels through the sensing lines during the first sensing period, and a global amplifier which supplies a second sensing voltage to the data lines during a second sensing period different from the first sensing period. The sensor receives a second sensing signal corresponding to the second sensing voltage from the pixels through the sensing lines during the second sensing period, and generates compensation data based on a difference value between the first sensing signal and the second sensing signal.

Abstract: A benzofuran-based N-acylhydrazone derivative according to the present invention has an excellent anticancer effect while having low toxicity and excellent solubility, and thus a pharmaceutical composition comprising the derivative can be usefully used to prevent or treat a cell proliferative disorder including various cancers.

Abstract: The present invention relates to a composition for preventing, alleviating or treating inflammatory diseases, comprising, as an active ingredient, an acylhydrazone derivative compound, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. an acylhydrazone derivative compound, a stereoisomer thereof or a pharmaceutically acceptable salt thereof, of the present invention, effectively inhibits inflammatory cytokines and inflammatory signaling pathways, thereby effectively alleviating symptoms of inflammatory diseases such as dermatitis. Therefore, the composition according to the present invention may be effectively used for the prevention, alleviation or treatment of inflammatory diseases.

Abstract: A display device includes: a display panel including a plurality of pixels; a source driver for outputting a target initialization voltage in an analog format to the pixels through sensing lines; and a timing controller for providing the source driver with a data control signal including packet information associated with the target initialization voltage. The packet information is in a digital format. The source driver includes a digital-analog converter which generates the target initialization voltage in the analog format, based on the packet information.

Abstract: A composition containing colchicine and its uses are disclosed. The composition enhances the expression amount of filaggrin that is highly related to the onset of allergic skin diseases, enhances skin moisturizing effects to thereby improve the skin barrier function, and in addition, controls inflammatory responses by allergic skin diseases. Therefore, methods for prevention and/or treatment of allergic skin diseases and/or pruritus cutaneous and skin moisturization and skin condition improvement are disclosed.

Abstract: A display device includes: a display panel including a plurality of pixels; a source driver for outputting a target initialization voltage in an analog format to the pixels through sensing lines; and a timing controller for providing the source driver with a data control signal including packet information associated with the target initialization voltage. The packet information is in a digital format. The source driver includes a digital-analog converter which generates the target initialization voltage in the analog format, based on the packet information.

Abstract: A display device includes a display unit including a plurality of pixels, a scan driver applying a scan signal to a plurality of scan lines, a data driver applying a data signal to a plurality of data lines, and a power supply unit supplying a driving voltage to at least one among the display unit, the scan driver, and the data driver. The power supply unit includes an inductor connected between an input terminal to which an input voltage is input and a driving voltage output terminal to which the driving voltage is output, a switch connected between the inductor and a ground, and a switch controller outputting a first ramp pulse having a first frequency at a first load of the display device and outputting a second ramp pulse having a second frequency at a second load of the display device.

Abstract: A display device includes a display panel including a plurality of pixels connected to data lines and sensing lines, a data driver including a plurality of buffer amplifiers which supplies a first sensing voltage to the data lines during a first sensing period and a sensor which receives a first sensing signal from the pixels through the sensing lines during the first sensing period, and a global amplifier which supplies a second sensing voltage to the data lines during a second sensing period different from the first sensing period. The sensor receives a second sensing signal corresponding to the second sensing voltage from the pixels through the sensing lines during the second sensing period, and generates compensation data based on a difference value between the first sensing signal and the second sensing signal.

Abstract: The present invention relates to: an indole derivative, which is a novel cell mitosis inhibitor; a stereoisomer thereof or a pharmaceutically acceptable salt thereof; a use thereof as a therapeutic agent; a composition containing the same and a treatment method using the composition; and a preparation method therefor. According to the present invention, the indole derivative, the stereoisomer thereof or the pharmaceutically acceptable salt thereof, inhibits the tubulin polymerization during mitosis so as to induce apoptosis, and has an excellent anti-cancer effect also in cancer cells having multiple drug resistance.

Abstract: A display device includes a display unit including a plurality of pixels, a scan driver applying a scan signal to a plurality of scan lines, a data driver applying a data signal to a plurality of data lines, and a power supply unit supplying a driving voltage to at least one among the display unit, the scan driver, and the data driver. The power supply unit includes an inductor connected between an input terminal to which an input voltage is input and a driving voltage output terminal to which the driving voltage is output, a switch connected between the inductor and a ground, and a switch controller outputting a first ramp pulse having a first frequency at a first load of the display device and outputting a second ramp pulse having a second frequency at a second load of the display device.

Abstract: A display device includes a display panel, a power supply, a signal controller configured to generate first and second clock signals having a period, a clock signal generator configured to generate a gate clock signal that is raised to a high level voltage in synchronization with the first clock signal, and that falls to a low level voltage in synchronization with the second clock signal, generate a panel separation signal by comparing a voltage of the gate clock signal with a first reference voltage during a falling period during which the gate clock signal falls, and transfer the panel separation signal to the power supply or the signal controller, and a gate driver configured to sequentially apply a gate signal by using the gate clock signal, wherein the power supply or the signal controller is configured to stop outputting depending on the panel separation signal.

Abstract: A display device includes a display unit including a plurality of pixels, a scan driver applying a scan signal to a plurality of scan lines, a data driver applying a data signal to a plurality of data lines, and a power supply unit supplying a driving voltage to at least one among the display unit, the scan driver, and the data driver. The power supply unit includes an inductor connected between an input terminal to which an input voltage is input and a driving voltage output terminal to which the driving voltage is output, a switch connected between the inductor and a ground, and a switch controller outputting a first ramp pulse having a first frequency at a first load of the display device and outputting a second ramp pulse having a second frequency at a second load of the display device.

Abstract: A display device includes a display panel, a power supply, a signal controller configured to generate first and second clock signals having a period, a clock signal generator configured to generate a gate clock signal that is raised to a high level voltage in synchronization with the first clock signal, and that falls to a low level voltage in synchronization with the second clock signal, generate a panel separation signal by comparing a voltage of the gate clock signal with a first reference voltage during a falling period during which the gate clock signal falls, and transfer the panel separation signal to the power supply or the signal controller, and a gate driver configured to sequentially apply a gate signal by using the gate clock signal, wherein the power supply or the signal controller is configured to stop outputting depending on the panel separation signal.

Abstract: The present invention relates to a composition for preventing, alleviating or treating inflammatory diseases, comprising, as an active ingredient, an acylhydrazone derivative compound, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. an acylhydrazone derivative compound, a stereoisomer thereof or a pharmaceutically acceptable salt thereof, of the present invention, effectively inhibits inflammatory cytokines and inflammatory signaling pathways, thereby effectively alleviating symptoms of inflammatory diseases such as dermatitis. Therefore, the composition according to the present invention may be effectively used for the prevention, alleviation or treatment of inflammatory diseases.

Abstract: A display device includes a timing controller configured to supply a first set signal to a data control signal line in a first frequency mode, and to supply a second set signal and a data signal to the data control signal line in a second frequency mode that is different from the first frequency mode, a data driver configured to recover the data signal supplied to the data control signal line according to a signal recovery characteristic value, to generate a plurality of data voltages based on the recovered data signal, and to adjust the signal recover characteristic value based on the first set signal and the second set signal, and a display unit including a plurality of pixels that emit lights with gray scales corresponding to the plurality of data voltages.